Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123 Administered Orally to Healthy Adults

Trial Profile

Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123 Administered Orally to Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs CRS 3123 (Primary)
  • Indications Clostridium infections
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Jun 2016 Status changed from recruiting to completed.
    • 02 Oct 2014 Planned End Date changed from 1 Mar 2015 to 1 Jun 2015 according to ClinicalTrials.gov record.
    • 02 Oct 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Dec 2014 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top